Department of Diagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan, Kansas, USA.
FEMS Microbiol Lett. 2019 Feb 1;366(4). doi: 10.1093/femsle/fnz037.
Enterotoxigenic Escherichia coli (ETEC) producing type Ib heat-stable toxin (STa) are a main cause of children's diarrhea and travelers' diarrhea, thus STa needs to be targeted in ETEC vaccine development. However, because this 19-amino acid STa is poorly immunogenic, attempts to genetically fuse or chemically couple it to carrier proteins have been made to enhance STa immunogenicity. In this study, we selected one genetic fusion and one chemical conjugate to comparatively evaluate STa immunogenicity. The genetic fusion is 3xSTaN12S-mnLTR192G/L211A carrying three toxoid (STaN12S) genetically fused to a double mutant LT monomer (mnLTR192G/L211A); the chemical conjugate is BSA-STaA14T, which has toxoid STaA14T chemically coupled to bovine serum albumin (BSA). We immunized mice with the STa toxoid fusion and chemical conjugates, and examined antibody responses. Furthermore, we immunized pigs and evaluated derived antibodies for efficacy to passively provide protection against ETEC diarrhea using a piglet model. Data showed that mice subcutaneously immunized with BSA-STaA14T or 3xSTaN12S-mnLTR192G/L211A developed a strong anti-STa antibody, and the induced antibodies exhibited equivalent toxin-neutralizing activities. Pigs immunized with 3xSTaN12S-mnLTR192G/L211A or BSA-STaA14T developed similar levels of anti-STa antibodies; piglets with passively acquired antibodies induced by the genetic fusion appeared better protected against STa + ETEC. Results from the current study indicate that the fusion and conjugate approaches are viable options for facilitating STa immunogenicity and developing ETEC vaccines.
肠产毒性大肠杆菌(ETEC)产生的 I 型耐热毒素(STa)是儿童腹泻和旅行者腹泻的主要原因,因此 STa 需要成为 ETEC 疫苗开发的目标。然而,由于这种 19 个氨基酸的 STa 免疫原性较差,因此尝试将其基因融合或化学偶联到载体蛋白上以增强 STa 的免疫原性。在这项研究中,我们选择了一种基因融合和一种化学缀合物来比较评估 STa 的免疫原性。基因融合物是 3xSTaN12S-mnLTR192G/L211A,它携带三个类毒素(STaN12S)基因融合到一个双突变 LT 单体(mnLTR192G/L211A)上;化学缀合物是 BSA-STaA14T,它将类毒素 STaA14T 化学偶联到牛血清白蛋白(BSA)上。我们用 STa 类毒素融合物和化学缀合物免疫小鼠,并检测了抗体反应。此外,我们用猪进行免疫,并评估了衍生抗体对使用仔猪模型被动提供抗 ETEC 腹泻保护的功效。数据表明,皮下免疫 BSA-STaA14T 或 3xSTaN12S-mnLTR192G/L211A 的小鼠产生了强烈的抗 STa 抗体,诱导的抗体具有相当的毒素中和活性。免疫 3xSTaN12S-mnLTR192G/L211A 或 BSA-STaA14T 的猪产生了类似水平的抗 STa 抗体;通过基因融合被动获得抗体的仔猪对 STa+ETEC 的保护效果更好。当前研究的结果表明,融合和缀合方法是促进 STa 免疫原性和开发 ETEC 疫苗的可行选择。